OTC Markets EXMKT - Delayed Quote USD
Affymax, Inc. (AFFY)
0.0008
0.0000
(0.00%)
At close: April 23 at 4:00:00 PM EDT
Breakdown
TTM
Total Revenue
42
Gross Profit
42
Operating Expense
4,748
Operating Income
-4,706
Other Income Expense
7,772
Pretax Income
3,066
Net Income Common Stockholders
3,066
Diluted NI Available to Com Stockholders
3,066
Basic EPS
0.08
Diluted EPS
0.08
Basic Average Shares
37,453
Diluted Average Shares
37,453
Total Operating Income as Reported
-5,094
Total Expenses
4,748
Net Income from Continuing & Discontinued Operation
3,066
Normalized Income
-4,706
EBIT
3,066
EBITDA
3,066
Reconciled Depreciation
148
Net Income from Continuing Operation Net Minority Interest
3,066
Total Unusual Items Excluding Goodwill
7,772
Total Unusual Items
7,772
Normalized EBITDA
-4,706
12/27/57281 - 12/15/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NNBP Nanobac Pharmaceuticals, Incorporated
0.0001
0.00%
ROTH PharmaRoth Labs, Inc.
0.0001
0.00%
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1390
0.00%
IGXT IntelGenx Technologies Corp.
0.1700
0.00%
NBY NovaBay Pharmaceuticals, Inc.
0.5772
-1.27%
OGEN Oragenics, Inc.
0.1940
+3.74%
RLMD Relmada Therapeutics, Inc.
0.6900
+82.54%
GALT Galectin Therapeutics Inc.
1.3400
+0.75%
TH.TO Theratechnologies Inc.
3.7350
-1.45%
VIR Vir Biotechnology, Inc.
5.97
+2.93%